What starting materials must the client provide, and what formats are accepted?

Clients may provide synthetic DNA fragments (linear or in plasmids), DNAs from cell lines or tissues. Purified protein targets for downstream screening are optional but recommended for validation.

Can the library be constructed from non-standard sources, such as de novo synthetic designs or engineered non-antibody scaffolds?

Yes. We fully support library construction from diverse non-standard sources, including de novo synthetic designs (e.g., rationally designed structural loops, focused mutagenesis at targeted interfacial residues) and modified natural protein domains. For every non-antibody scaffold project, a comprehensive feasibility consultation is provided to assess codon optimization, structural stability, and yeast display compatibility.

How is library diversity defined and measured?

Diversity is defined as the number of unique transformants containing full-length, in-frame inserts. Measurement: plating serial dilutions followed by colony counting; confirmed by sequencing depth. For synthetic libraries, theoretical diversity is calculated from degenerate codon composition and validated empirically.

What downstream applications are supported after library construction?

Constructed libraries are directly compatible with FACS-based screening for binding, off-rate selection, enzymatic activity (using fluorescent substrates), or stability at elevated temperature or denaturants. Libraries can also be archived for multi-round selections or converted to soluble formats for validation.

Yeast Display Non-Antibody Protein Library Construction Services

Services Workflow Platform Advantages Related Services FAQ

Protein Engineering via Yeast Display

Fig.1 Protein Origami (Creative Biolabs AI)

Creative Biolabs provide tailored yeast display non-antibody protein library construction services to overcome major challenges in protein engineering. Our services focus on protein-peptide binding affinity maturation, enzyme-substrate specificity remodeling, catalytic activity promotion and substrate specificity alteration. Scenario applications involve MHC-II epitope engineering, LplA peptide substrate optimization and glucose oxidase activity enhancement.

Discuss your project with an expert

Peer-level Related Services

Fig.2 Antibody (Creative Biolabs AI)

Yeast Display Antibody Library Construction Services

High-diversity libraries for antibody discovery and engineering.

Fig.3 Molecular structure (Creative Biolabs AI)

Yeast Display Peptide Library Construction Service

Custom-built random and structurally constrained peptide libraries for diverse ligand screening campaigns.

Fig.4 Double helix (Creative Biolabs AI)

Yeast Display cDNA Library Construction Service

Native proteome representation from disease or immune tissues.

Downstream Compatible Services

Fig.5 Antibody Conformation (Creative Biolabs AI)

Yeast Display T Cell Receptor Library Construction Service

Yeast Display Protein Scaffold Library Construction Service

Discover the most suitable solution tailored to your needs – Get in touch with our team today!

Follow Clear Delivery Workflows

Library design and codon optimization

Electroporation into yeast display strains

Culture under optimized induction conditions

Quality-controlled library aliquoting and validation

Deliverables
	Cryopreserved library aliquots Sequencing validation reports Expression and display efficiency analysis by flow cytometry

Learn More About Process

Platform - Core Strengths

The yeast display platform combines eukaryotic protein folding and post-translational modification with quantitative, high-throughput fluorescence-activated cell sorting (FACS). View Yeast Platform Details

Key Advantages

Fig.8 Inventory (Creative Biolabs AI)

Eukaryotic expression

Correct disulfide bonds and glycosylation for mammalian targets

Fig.9 Five-pointed star (Creative Biolabs AI)

Quantitative screening

Direct cell-surface-based affinity and stability selection

Fig.10 Setting (Creative Biolabs AI)

Robust diversity

Libraries exceeding 10⁸ unique variants achievable

Fig.11 Increase (Creative Biolabs AI)

Seamless integration

From library construction to downstream selection

→ Connect with Our Yeast Display Experts

Why Leading Teams Prefer Us

Fig.12 Curve (Creative Biolabs AI)

Mature surface display platform
A wealth of finished yeast display library projects covers therapeutic antibody development, industrial enzyme engineering and protein scaffold design.

Fig.13 Idea (Creative Biolabs AI)

Direct Communication Between Scientists and Clients
PhD project managers manage projects end-to-end, offering weekly progress updates and prompt technical troubleshooting.

Fig.14 Cycle (Creative Biolabs AI)

Integrated FACS with yeast display
In-house cell sorting and high-parameter flow cytometry enabling precise library characterization and enrichment.

Fig.15 Shield (Creative Biolabs AI)

Confidentiality-first operations
Client sequencing data and exclusive proprietary targets are excluded from marketing and internal research and development.

Request a Custom Technical Proposal →

Browse More Associated Services

Explore our complete suite of yeast display technology offerings.

Fig.16 Plan (Creative Biolabs AI)

Frequently Asked Questions

What starting materials must the client provide, and what formats are accepted?
Clients may provide synthetic DNA fragments (linear or in plasmids), DNAs from cell lines or tissues. Purified protein targets for downstream screening are optional but recommended for validation.
Can the library be constructed from non-standard sources, such as de novo synthetic designs or engineered non-antibody scaffolds?
Yes. We fully support library construction from diverse non-standard sources, including de novo synthetic designs (e.g., rationally designed structural loops, focused mutagenesis at targeted interfacial residues) and modified natural protein domains. For every non-antibody scaffold project, a comprehensive feasibility consultation is provided to assess codon optimization, structural stability, and yeast display compatibility.
How is library diversity defined and measured?
Diversity is defined as the number of unique transformants containing full-length, in-frame inserts. Measurement: plating serial dilutions followed by colony counting; confirmed by sequencing depth. For synthetic libraries, theoretical diversity is calculated from degenerate codon composition and validated empirically.
What downstream applications are supported after library construction?
Constructed libraries are directly compatible with FACS-based screening for binding, off-rate selection, enzymatic activity (using fluorescent substrates), or stability at elevated temperature or denaturants. Libraries can also be archived for multi-round selections or converted to soluble formats for validation.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: